Cryo-EM structures of CRAF/MEK1/14-3-3 complexes in autoinhibited and open-monomer states reveal features of RAF regulation

D Dong Man Jang K Kayla Boxer B Byung Hak Ha E Emre Tkacik T Talya Levitz S Shaun Rawson (Harvard Cryo-Electron Microscopy Center for Structural Biology, Harvard Medical School) R Rebecca J. Metivier (Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.) A Anna Schmoker H Hyesung Jeon M Michael J. Eck

Abstract

Abstract CRAF (RAF1) is one of three RAF-family kinases that initiate MAP kinase signaling in response to activated RAS and is essential for oncogenic signaling from mutant KRAS. Like BRAF, CRAF is regulated by 14-3-3 engagement and by intramolecular autoinhibitory interactions of its N-terminal regulatory region. Unlike BRAF, it is thought to require tyrosine phosphorylation in its N-terminal acidic (NtA) motif for full catalytic activation. Here we describe cryo-EM reconstructions of full-length CRAF in complex with MEK1 and a 14-3-3 dimer. These structures reveal a fully autoinhibited conformation analogous to that observed for BRAF and two “open monomer” states in which the inhibitory interactions of the CRD and 14-3-3 dimer are released or rearranged, but the kinase domain remains inactive. Structure-function studies of the NtA motif indicate that phosphorylation or acidic mutations in this segment increase catalytic activity by destabilizing the inactive conformation of the kinase domain. Collectively, these studies provide a structural foundation for understanding the shared and unique regulatory features of CRAF and will inform efforts to selectively block CRAF signaling in cancer.

Article Details

Volume / Issue Vol. 16, Issue 1
Published September 01, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (10)

D

Dong Man Jang

K

Kayla Boxer

B

Byung Hak Ha

E

Emre Tkacik

T

Talya Levitz

S

Shaun Rawson

Harvard Cryo-Electron Microscopy Center for Structural Biology, Harvard Medical School

R

Rebecca J. Metivier

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.

A

Anna Schmoker

H

Hyesung Jeon

M

Michael J. Eck